Navigation Links
Biotech Hall of Fame Inductees Announced
Date:10/8/2007

xt-generation life-science

tools and integrated systems for the large-scale analysis of genetic

variation and biological function.

Onyx Pharmaceuticals

Developer of innovative small molecule cancer treatments based on a

molecular understanding of cancer. Onyx's lead product is Nexavar(R)

(sorafenib) tablets, an oral multiple kinase inhibitor that targets

proteins involved in both tumor cell proliferation and angiogenesis

(the formation of new blood vessels to support cancer cell growth).

Vertex Pharmaceuticals

The Company is leading the development of the HCV protease inhibitor,

telaprevir (VX-950), and in 2007 is conducting a broad Phase 2

clinical program of this drug candidate. Vertex is also focused on the

development of VX-702, a p38 MAP kinase inhibitor for the treatment of

rheumatoid arthritis, and VX-770, an investigational drug candidate

for cystic fibrosis.

Special Recognition for an Individual

Jim Greenwood, President and CEO, Biotechnology Industry Organization

(BIO)

BIO represents more than 1,100 biotechnology companies, academic

institutions, state biotechnology centers and related organizations in

all 50 U.S. states and 31 other nations.

Susan D. Desmond-Hellmann, President, Product Development, Genentech

Inc.

Genentech is one of the biotech industry's leading companies and Dr.

Desmond-Hellmann has overseen the development of several promising

cancer drugs and the final testing phase of others.

John C. Martin, President and CEO, Gilead Sciences Inc.

Dr. Martin joined Gilead Sciences in 1990 and has served as President

and Chief Executive Officer since 1996. The company has expanded

rapidly over the past two decades, with annual revenues now exceeding

$3 billion
'/>"/>

SOURCE Burrill & Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. The state of global biotech: An Ernst & Young perspective
2. Olympics of biotechnology has international flavor
3. Biotech officials praise focus of new venture fund
4. Getting noticed in Genetown: Wisconsin biotech on display
5. Madison biotech NimbleGen files for IPO; one of states best-funded firms
6. Wisconsin biotech firm receives $107K NIH grant
7. Biotech executive books a career flight thats closer to home
8. Manufacturing partnership will move into biotech and biomedical spaces
9. Wisconsin wont get Georgia biotech without a fight
10. The 10 biggest events shaping biotech in 2006
11. Gala Biotech among companies sold for $3.3 billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... ... supplier, announces the launch of their 2nd generation cell therapy POD® design. The ... CT, but it also represents a new POD® design. , “G-CON first ...
(Date:7/29/2015)... July 29, 2015  Therapath Neuropathology ( www.Therapath.com ... partnerships with VA and Military Medical centers both ... Density (ENFD) and Sweat Gland Nerve Fiber Density ... ( https://therapath.com/skin ). Demonstration of ... (ENFD) on punch skin biopsy is a highly ...
(Date:7/29/2015)... July 29, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. ... medicine company, is pleased to announce that the final ... have been locked.  Prototypes for industrial and regulatory ... an application for CE mark clearance to market ... in 2016. (Photo: http://photos.prnewswire.com/prnh/20150729/248373 )  ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel, a nighttime-specific product that targets ... amount of sugars that are able to enter fat cells, inhibiting the formation ...
Breaking Biology Technology:G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3Neuropathology services for VA and Military health systems 2RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 2RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 3RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 4RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 5Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel 2Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel 3
... N.Y. A new technique for growing single-crystal ... enable the development of smaller, more powerful heat ... , Researchers at Rensselaer Polytechnic Institute have discovered ... up of two single crystals using a biomolecular ...
... In conjunction with,CorVel Corporation,s (Nasdaq: CRVL ) quarterly earnings release, CorVel ... on Tuesday, August 5th at 11:30 am Eastern Time., Event: ... by: Dan Starck, President and CEO ... Date: 11:30 am Eastern Time, Tuesday, ...
... July 17 Researchers at Fred Hutchinson Cancer,Research ... from the,National Human Genome Research Institute to better ... The Hutchinson Center is one of,four U.S. research ... this effort., The Hutchinson Center project, led ...
Cached Biology Technology:'Nanosculpture' could enable new types of heat pumps and energy converters 2CorVel Corporation Announces Earnings Release Webcast 2Hutchinson Center Receives $7.6 Million Federal Grant to Study How Genetic Variations Influence Risk of Common Diseases 2Hutchinson Center Receives $7.6 Million Federal Grant to Study How Genetic Variations Influence Risk of Common Diseases 3
(Date:7/21/2015)... , July 21, 2015  NXT-ID, Inc. ... a biometric authentication company focused on the growing ... smart wallet, announces that it has filed provisional ... and Method. This invention highlights ... only authorizes an account, but also the user ...
(Date:7/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), a ... it will report financial results for the fourth quarter ... after the close of market. The company will host ... 2:00 p.m. PT (5:00 p.m. ET), during which management ... on the live call, analysts and investors should dial ...
(Date:7/8/2015)... NEW YORK , July 8, 2015  BD ... announced BD & Guidepoint Mentor, a new ... to Guidepoint,s expert network services. BD ... technologies to improve healthcare delivery and outcomes and, with ... start-up entrepreneur will be able to directly engage with ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3
... CA--A team of marine scientists has found that toxin-producing algae ... common in the open ocean, where the addition of iron ... the harmful algae. The new findings, reported this week in ... add to concerns about proposals to use iron fertilization of ...
... Medicine researchers at the Robert H. Lurie Comprehensive Cancer Center ... made from a chemical in soy could prevent the movement ... the body. These findings will be presented at the ... Prevention Research Conference. Genistein, a natural chemical found in ...
... 8, 2010 A study published in the November ... the Alzheimer,s Association suggests that taking docosahexaenoic acid ... with mild cognitive impairments. This is promising news ... to maintain memory and support overall cognitive health. The ...
Cached Biology News:Iron stimulates blooms of toxin-producing algae in open ocean, study finds 2Soy may stop prostate cancer spread 2DHA improves memory and cognitive function in older adults 2
Fetal Calf Serum Replacement (Bistec) serum...
NEWBORN CALF SERUM AND PLASMA...
... reagent for Virus isolation ... unique water insoluble Elastomeric ... and chaotropes; Engineered to ... viruses while preserving infectivity; ...
Mouse monoclonal [Ley 37D/G6] to LKB1 ( Abpromise for all tested applications). entrezGeneID: 6794 SwissProtID: Q15831...
Biology Products: